{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:31:40Z","timestamp":1788427900086,"version":"build-2803163510"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,9]]},"abstract":"<jats:sec>\n                    <jats:title>Context:<\/jats:title>\n                    <jats:p>Vitiligo is an acquired pigmentary disorder of the skin that is characterized by circumscribed, depigmented macules, and patches.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims:<\/jats:title>\n                    <jats:p>To compare the therapeutic efficacy and safety of microneedling combined with topical 5-fluorouracil solution versus microneedling alone on stable patches of vitiligo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Settings and Design:<\/jats:title>\n                    <jats:p>Hospital-based interventional prospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and Material:<\/jats:title>\n                    <jats:p>We selected 46 patients in the age group of 10\u201350 years having patch stability of at least 1-year duration. The patients were randomly assigned into two groups of 23 patients each. Group A was treated with microneedling followed by application of 5-fluorouracil which was available in the form of a solution (50 mg\/mL) whereas Group B was treated with microneedling alone. The procedure was repeated after every 15 days up to 4 months and patient follow-up along with the grading of repigmentation was done till 6 months. The side effects were noted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>\n                      Statistical Package for Social Sciences (SPSS) software, version 25.0. The results were analyzed using the Chi-square test and\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -test and\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05 was considered significant.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>At the end of 6 months, excellent response (&gt;75% repigmentation) was reported in 35 patches (48.6%) in Group A treated with microneedling combined with 5-fluorouracil whereas only 12 patches (16.9%) showed an excellent response in Group B treated with microneedling alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Combining microneedling with 5-fluorouracil is a simple, safe, well tolerable, and effective modality than microneedling alone for treating small localized vitiligo patches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_130_21","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T12:21:23Z","timestamp":1716985283000},"page":"574","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["A Comparative Study of Microneedling Combined with Topical 5-Fluorouracil versus Microneedling Alone in Treatment of Localized Stable Vitiligo"],"prefix":"10.4103","volume":"66","author":[{"given":"Shaiphali","family":"Chhabra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatendra S","family":"Chahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-36-20240829","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: A comprehensive overview: Part I.Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R2-36-20240829","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2340\/0001555574124128","article-title":"High frequency of thyroid dysfunction in patients with vitiligo","volume":"74","author":"Heged\u00fcs","year":"1994","journal-title":"Acta Derm Venereol"},{"key":"R3-36-20240829","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/jocd.12440","article-title":"Comparison between the efficacy of microneedling combined with 5-fluorouracil vs. microneedling with tacrolimus in the treatment of vitiligo","volume":"17","author":"Mina","year":"2018","journal-title":"J Cosmet Dermatol"},{"key":"R4-36-20240829","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archderm.1983.01650330014006","article-title":"Topically administered fluorouracil in vitiligo","volume":"119","author":"Tsuji","year":"1983","journal-title":"Arch Dermatol"},{"key":"R5-36-20240829","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-4632.2007.03226.x","article-title":"Comparative evaluation of the therapeutic efficacy of dermabrasion, dermabrasion combined with topical 5% 5-fluorouracil cream, and dermabrasion combined with topical placentrex gel in localized stable vitiligo","volume":"46","author":"Sethi","year":"2007","journal-title":"Int J Dermatol"},{"key":"R6-36-20240829","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4103\/ijdvl.IJDVL_386_16","article-title":"Efficacy of topical 5% fluorouracil needling in vitiligo","volume":"84","author":"Shashikiran","year":"2018","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R7-36-20240829","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/1523-1747.ep12497951","article-title":"Leukotriene C4 and TGF-alpha are stimulators of human melanocyte migration in vitro","volume":"98","author":"Morelli","year":"1992","journal-title":"J Invest Dermatol"},{"key":"R8-36-20240829","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/1523-1747.ep12284392","article-title":"Leukotrienes C4 and D4 as potent mitogens for cultured human neonatal melanocytes","volume":"93","author":"Morelli","year":"1989","journal-title":"J Invest Dermatol"},{"key":"R9-36-20240829","first-page":"144","article-title":"Efficacy of laser dermabrasion followed by topical 5-fluorouracil in the treatment of stable vitiligo","volume":"7","author":"George","year":"2017","journal-title":"Int J Health Sci Res"},{"key":"R10-36-20240829","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/ijpd.IJPD_107_16","article-title":"A study of clinico-epidemiological and dermoscopic patterns of vitiligo in pediatric age group","volume":"18","author":"Gandhi","year":"2017","journal-title":"Indian J Paediatr Dermatol"},{"key":"R11-36-20240829","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/j.1524-4725.2011.02127.x","article-title":"Combination of microdermabrasion and 5-fluorouracil to induce repigmentation in vitiligo: An observational study","volume":"37","author":"Garg","year":"2011","journal-title":"Dermatol Surg"},{"key":"R12-36-20240829","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/2321-8568.190142","article-title":"Comparative evaluation of the therapeutic efficacy of microneedling alone or microneedling combined with topical 5-fluorouracil in localized stable childhood vitiligo","volume":"6","author":"Ghiya","year":"2016","journal-title":"Adv Human Biol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_130_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:45:28Z","timestamp":1787769928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_130_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_130_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]}}}